Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Ocrelizumab may cause total body hair loss in some patients.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ocrelizumab may cause delayed hair loss in some patients.

Etanercept may not prevent alopecia areata from coming back.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

CTP-543 is generally safe for treating alopecia areata.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Rituximab improved her dermatomyositis better than usual treatments.

Apremilast improved symptoms in patients with severe skin conditions.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Clofazimine effectively treated ashy dermatosis in a patient.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.